Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP208885.RACmhAMDnR7KgEbBqMaz9oBYgXQOUErHzEkwsJ3tzl200130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP208885.RACmhAMDnR7KgEbBqMaz9oBYgXQOUErHzEkwsJ3tzl200130_assertion type Assertion NP208885.RACmhAMDnR7KgEbBqMaz9oBYgXQOUErHzEkwsJ3tzl200130_head.
- NP208885.RACmhAMDnR7KgEbBqMaz9oBYgXQOUErHzEkwsJ3tzl200130_assertion description "[Methotrexate (MTX), 5-florouracil (5-Fu), and cisplatin (CDDP) are commonly used for breast carcinoma treatment in clinics; however, patients with HER2/neu overexpression exhibit resistance to these anticancer drugs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208885.RACmhAMDnR7KgEbBqMaz9oBYgXQOUErHzEkwsJ3tzl200130_provenance.
- NP208885.RACmhAMDnR7KgEbBqMaz9oBYgXQOUErHzEkwsJ3tzl200130_assertion evidence source_evidence_literature NP208885.RACmhAMDnR7KgEbBqMaz9oBYgXQOUErHzEkwsJ3tzl200130_provenance.
- NP208885.RACmhAMDnR7KgEbBqMaz9oBYgXQOUErHzEkwsJ3tzl200130_assertion SIO_000772 17885815 NP208885.RACmhAMDnR7KgEbBqMaz9oBYgXQOUErHzEkwsJ3tzl200130_provenance.
- NP208885.RACmhAMDnR7KgEbBqMaz9oBYgXQOUErHzEkwsJ3tzl200130_assertion wasDerivedFrom befree-20140225 NP208885.RACmhAMDnR7KgEbBqMaz9oBYgXQOUErHzEkwsJ3tzl200130_provenance.
- NP208885.RACmhAMDnR7KgEbBqMaz9oBYgXQOUErHzEkwsJ3tzl200130_assertion wasGeneratedBy ECO_0000203 NP208885.RACmhAMDnR7KgEbBqMaz9oBYgXQOUErHzEkwsJ3tzl200130_provenance.